The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALTRIA GROUP INC COM 02209S103 2,460 60,000 SH   SOLE   60,000 0 0
AQUABOUNTY TECHNOLOGIES INC COM NEW 03842K200 159,606 18,219,824 SH   SOLE   18,219,824 0 0
EMERGENT BIOSOLUTIONS INC COM 29089Q105 341 3,810 SH   SOLE   3,810 0 0
HALOZYME THERAPEUTICS INC COM 40637H109 75,258 1,762,072 SH   SOLE   1,762,072 0 0
INTERNATIONAL BUSINESS MACHS COM 459200101 2,643 21,000 SH   SOLE   21,000 0 0
KINDER MORGAN INC DEL COM 49456B101 2,461 180,000 SH   SOLE   180,000 0 0
MAXLINEAR INC COM 57776J100 211 5,530 SH   SOLE   5,530 0 0
PRECIGEN INC COM 74017N105 833,789 81,744,063 SH   SOLE   81,744,063 0 0
PTC THERAPEUTICS INC COM 69366J200 14,465 237,015 SH   SOLE   237,015 0 0
QUAKER CHEM CORP COM 747316107 327 1,290 SH   SOLE   1,290 0 0
VERIZON COMMUNICATIONS INC COM 92343V104 2,409 41,000 SH   SOLE   41,000 0 0